EDUCATION

1981-1985 Harvard Medical School (Pathology) and Dana-Farber Cancer Institute (Postdoctoral Fellowship)
1981  Ph.D. University of California, Irvine (Microbiology)
1975  B.A. University of California, Los Angeles (Biology)

PROFESSIONAL EXPERIENCE

2012-2013 President, Cancer Biology Training Consortium
2010-2013 Board of Directors, Cancer Biology Training Consortium
2010 Consultant, Bristol-Myers Squibb
2010 Consultant, AstraZeneca
2010 Consultant, Sanofi-Aventis
2010-2012 Chair, Pancreatic Cancer Action Network– AACR Innovative Grants Scientific Review Committee
2010-2011 AACR Program Committee
2009-present Editorial Board, Bioscience Reports
2009-present Editorial Board, Small GTPases
2009-present Editorial Board, Genes & Cancer
2008 Senior Academic Visitor of Wolfson College, Cambridge, UK
2008-present Scientific Advisory Board, Lustgarten Foundation for Pancreatic Cancer Research
2008-present Consultant, Millipore
2001-2011 Reviewer, Italian Association Cancer Research
2007-2008 AACR Program Committee
2007-2008 Member, Children’s Tumor Foundation, Drug Discovery Initiative Panel
2007 Member, AACR Grants Subcommittee for Pancreatic Research Fellowship
2006-2009 Member, DOD Neurofibromatosis Research Program Integration Panel
2006- present Editorial Board, Journal Molecular Signaling
2004-2007 AACR Laboratory Research Awards Selection Committee
2005- present Member, Cancer Biology Training Consortium
2003 Consultant, Chemicon
2003 Consultant, Upstate Biotechnology
2003 Consultant, Odyssey Thera
2002 Consultant, PPD Discovery
2002-present Member, Faculty of 1000
2001 External Reviewer, Wake Forest Cancer Center Program
2000-2002 Associate Editor, Cancer Research
2000-present Editorial Board, Cancer Letters
2000-present Consultant, Tularik
1998-present  Director, NIH Cancer Cell Biology Training Grant
1998-present  Board of Advisors, Children’s Tumor Foundation
1998-present Member, Curriculum in Toxicology, UNC-Chapel Hill
1998 Consultant, Schering-Plogh
1997 Consultant, Dupont-Merck
1996-1997 Consultant, Biomeasure
1996 Consultant, Merck
1995-1996 Consultant, Parke-Davis
1995-present Professor, Department of Pharmacology Member, UNC Lineberger Comprehensive Cancer Center and Member, Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill
1992-1995 Associate Professor, Department of Pharmacology Member, UNC Lineberger Comprehensive Cancer Center and Member, Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill
1992-1996 Member, NIH Pathology B Study Section
1992-1994 Consultant, Bristol-Myers Squibb
1992-1993 Consultant, Dupont Merck Pharmaceuticals
1991-1993 Consultant, Eisai Research Institute
1990-present Consultant, Special Review Committee, NCI
1989-1991 Ad Hoc Member, NIH Pathology B Study Section
1989-1992 Staff Scientist, The Burnham Institut
1985-1989 Assistant Staff Scientist, The Burnham Institute
1981-1985 Postdoctoral Fellow, Harvard Medical School and the Dana-FarberPostdoctoral Fellow, Harvard Medical School and the Dana-Farber Cancer Institute

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s